Evidence-based guide to Cytotec (misoprostol) for early medical abortion: how it works, WHO-aligned protocols, what to expect, warning signs, and follow-up. Find patient medical information for Misoprostol (Cytotec) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings Medscape - Indication-specific dosing for Cytotec (misoprostol), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost. Misoprostol was FDA approved on December 27, 1988, under the brand Cytotec. Generic misoprostol is available. Misoprostol side effects Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Misoprostol may cause serious side effects. Cytotec (Misoprostol) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources. Misoprostol (Cytotec) is often used to help pass a pregnancy following a missed miscarriage or spontaneous abortion. Here's what to expect. Misoprostol (Cytotec) is a prescription medication that's FDA approved to lower the risk of stomach ulcers in certain people who take nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen. Cytotec is an off-brand version of the medication Misoprostol, which is a synthetic version of the hormone prostaglandin. Cytotec was not originally developed to help induce labor and was instead used to treat stomach ulcers. What is Cytotec? Cytotec is used to prevent stomach ulcers during treatment with nonsteroidal anti-inflammatory drugs (NSAID) such as aspirin, ibuprofen, naproxen, celecoxib, diclofenac, indomethacin, meloxicam, and others. Cytotec- misoprostol tablet. DailyMed. 9 July 2021. Archived from the original on 18 April 2023. Retrieved 13 April 2023. List of nationally authorised medicinal products. Misoprostol (gastrointestinal indication). Procedure no.: PSUSA/00010353/202005 (PDF). European Medicines Agency. 14 January 2021. Archived (PDF) from the original on 29.